A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
Clinical trial NCT02340234 · COMPLETED
Trial details
- NCT number
- NCT02340234
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-04-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.